VAPA Antikörper (AA 29-92)
Kurzübersicht für VAPA Antikörper (AA 29-92) (ABIN1886325)
Target
Alle VAPA Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 29-92
-
Aufreinigung
- Purified by antigen-affinity chromatography.
-
Immunogen
- Synthetic peptide contain a sequence corresponding to a region within amino acids 29 and 92 of VAPA
-
-
-
-
Applikationshinweise
-
Suggested dilutions:
Western blotting: 1.500-1.3000
Immunohistochemistry: 1.50-1.500 -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- 0.1 M Tris-buffered saline with 10 % Glycerol (pH 7.0).0.01 % Thimerosal was added as a preservative.
-
Konservierungsmittel
- Thimerosal (Merthiolate)
-
Vorsichtsmaßnahmen
- Biohazard Informations: This product contains thimerosal which is hazardous.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store at -20 °C for long term preservation (recommended). Store at 4 °C for short term use.
-
-
- VAPA (VAMP (Vesicle-Associated Membrane Protein)-Associated Protein A, 33kDa (VAPA))
-
Andere Bezeichnung
- VAPA
-
Hintergrund
-
The protein encoded by this gene is a type IV membrane protein.It is present in the plasma membrane and intracellular vesicles.It may also be associated with the cytoskeleton.This protein may function in vesicle trafficking, membrane fusion, protein complex assembly and cell motility.Alternative splicing occurs at this locus and two transcript variants encoding distinct isoforms have been identified.[provided by RefSeq]
-
Molekulargewicht
- 28 kDa
-
Gen-ID
- 9218
-
NCBI Accession
- NP_919415, NM_194434
Target
-